Article Type
Changed
Fri, 01/04/2019 - 11:09
Display Headline
Targeting B-cell signaling pathways: a central role for Bruton’s tyrosine kinase

B-cell cancers constitute a large group of diseases with diverse clinical and pathological characteristics that arise from the B (bursal- or bone marrow-derived) lymphocytes of the immune system. B cells are involved in humoral immunity as part of the adaptive immune response. They display a unique B-cell receptor (BCR) on their surface which binds to a specific antigen. Antigen- binding activates the process of clonal expansion, during which the B cell reproduces to form an army of clones that secrete the same antibody. These antibodies then bind to the target antigen on foreign cells and initiate a range of immune responses that ultimately lead to the destruction of that cell.
 

Click on the PDF icon at the top of this introduction to read the full article.

 

Article PDF
Author and Disclosure Information

 

 

Issue
The Journal of Community and Supportive Oncology - 12(6)
Publications
Topics
Page Number
222-227
Legacy Keywords
B-cell receptor, BCR, signaling pathway, Bruton's tyrosine kinase, BTK, toll-like receptor, TLR
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

B-cell cancers constitute a large group of diseases with diverse clinical and pathological characteristics that arise from the B (bursal- or bone marrow-derived) lymphocytes of the immune system. B cells are involved in humoral immunity as part of the adaptive immune response. They display a unique B-cell receptor (BCR) on their surface which binds to a specific antigen. Antigen- binding activates the process of clonal expansion, during which the B cell reproduces to form an army of clones that secrete the same antibody. These antibodies then bind to the target antigen on foreign cells and initiate a range of immune responses that ultimately lead to the destruction of that cell.
 

Click on the PDF icon at the top of this introduction to read the full article.

 

B-cell cancers constitute a large group of diseases with diverse clinical and pathological characteristics that arise from the B (bursal- or bone marrow-derived) lymphocytes of the immune system. B cells are involved in humoral immunity as part of the adaptive immune response. They display a unique B-cell receptor (BCR) on their surface which binds to a specific antigen. Antigen- binding activates the process of clonal expansion, during which the B cell reproduces to form an army of clones that secrete the same antibody. These antibodies then bind to the target antigen on foreign cells and initiate a range of immune responses that ultimately lead to the destruction of that cell.
 

Click on the PDF icon at the top of this introduction to read the full article.

 

Issue
The Journal of Community and Supportive Oncology - 12(6)
Issue
The Journal of Community and Supportive Oncology - 12(6)
Page Number
222-227
Page Number
222-227
Publications
Publications
Topics
Article Type
Display Headline
Targeting B-cell signaling pathways: a central role for Bruton’s tyrosine kinase
Display Headline
Targeting B-cell signaling pathways: a central role for Bruton’s tyrosine kinase
Legacy Keywords
B-cell receptor, BCR, signaling pathway, Bruton's tyrosine kinase, BTK, toll-like receptor, TLR
Legacy Keywords
B-cell receptor, BCR, signaling pathway, Bruton's tyrosine kinase, BTK, toll-like receptor, TLR
Sections
Citation Override
JCSO 2014;12:222-227
Disallow All Ads
Alternative CME
Article PDF Media